Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LCTX.TA
- Price
- 2.98
- Stock movement down
- -7.80 (-1.85%)
- Company name
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology
- Market cap
- 94.47B
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 35.11%
- 3 year return
- -9.14%
- 5 year return
- 175.87%
- 10 year return
- -
Last updated: 2025-09-17
DIVIDENDS
LCTX.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 421.50 |
| Daily high | 424.00 |
| Daily low | 412.00 |
| Daily Volume | 4K |
| All-time high | 1008.00 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 13 Nov 2025 |
Downside potential
Loading...
Downside potential data
| LCTX.TA | S&P500 | |
| Current price drop from All-time high | -58.96% | -1.06% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 24 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -51.68% | -10.99% |
| Avg time to new high | 61 days | 12 days |
| Max time to new high | 1109 days | 1805 days |
COMPANY DETAILS
Marketcap
94.47B
Marketcap category
Large-cap
Description
Employees
Investor relations
-
SEC filings
CEO
Country
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...
October 10, 2025
Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the best performing penny stocks to buy now. On September 9, HC Wainwright reiterated a ‘Buy’ rating on the stock and a $9 price target, buoyed by ...
September 29, 2025
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Lineage Cell Therapeutics, Inc. is one of them. Lineage Cell Therapeutics, Inc. (NYSE:LCTX) is a c...
September 23, 2025
CARLSBAD, Calif., September 08, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell thera...
September 8, 2025
CARLSBAD, Calif., September 02, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell thera...
September 2, 2025
Health care stocks advanced late Tuesday afternoon with the NYSE Health Care Index rising 0.6% and t
August 26, 2025
CARLSBAD, Calif., August 26, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf," cell therapie...
August 26, 2025
Lineage Cell Therapeutics Inc (LCTX) showcases promising clinical trial results and strategic collaborations, while navigating increased expenses and market uncertainties.
August 13, 2025
Lineage Cell (LCTX) delivered earnings and revenue surprises of +50.00% and +75.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
August 12, 2025
CARLSBAD, Calif. AP) — Lineage Cell Therapeutics, Inc. LCTX) on Tuesday reported a loss of $30.5 million in its second quarter.
August 12, 2025
Next page